Physician profile
Yiming Avery Ching
NPI 1851490775
$12,667.13
in general payments reported to CMS, 2019-2025
10 companies · $346 in 2025
The $346 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,134 · 2020: $125 · 2022: $109 · 2023: $11K · 2024: $345 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,900 · Food and Beverage: $1,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,900.00 |
| Food and Beverage | $1,399.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $10,080.69 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Silk Road Medical, INC. | $1,319.66 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $328.33 | 2019-2023 | Zenith |
| Endologix LLC | $305.44 | 2023-2024 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System |
| Terumo Medical Corporation | $160.25 | 2024 | R2p Misago, Metacross Otw |
| Kerecis Limited | $132.28 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Penumbra, INC. | $123.33 | 2023 | Indigo System |
| Boston Scientific Corporation | $119.76 | 2025 | General - Vascular Intervention |
| Philips North America LLC | $51.57 | 2024 | (Br5) Peripheral Ivus |
| Janssen Pharmaceuticals, INC | $45.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yiming Ching listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.